Maria do Carmo Fajardo

Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.

Antônio Braga, Elza Maria Hartmann Uberti, Maria do Carmo Fajardo et al. · PubMed · 2014 · 61 citations · Full text

Medicine, Gynecology, Obstetrics +14

Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day Methotrexate with folinic acid versus bolus-dose Actinomycin-D, among Brazilian women

Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Adriana Gerhardt Vieira da Cunha et al. · Revista Brasileira Ginecologia e Obstetrícia · 2015 · 44 citations · Full text

Medicine, Gynecology, Pharmacotherapy +9

Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: A simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment

Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Adriana Gerhardt Vieira da Cunha et al. · Gynecologic Oncology · 2009 · 28 citations

Medicine, Gynecology, Obstetrics +10

Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy

Elza Maria Hartmann Uberti, Maria do Carmo Fajardo, Silvia Villa Verde Ribeiro Ferreira et al. · Gynecologic Oncology · 2009 · 18 citations

Medicine, Gynecology, Obstetrics +9

Treatment of patients with gestational trophoblastic neoplasia (GTN) in 12 South America referral centers: Results after 10 years since international FIGO consensus.

Gustavo Jankilevich, Elza Maria Hartmann Uberti, Antônio Braga et al. · Journal of Clinical Oncology · 2014 · 13 citations

Medicine, Gynecology, Oncology +13